Richard Smeyne

Last updated

Richard Jay Smeyne is a neuroscientist who is currently Professor and Chair of the Department of Neuroscience at Thomas Jefferson University, where he is also Director of the Jefferson Comprehensive Parkinson's Disease and Movement Disorder Center at the Vickie and Jack Farber Institute for Neuroscience. [1] [2] [3] His research is focused on the cell biology of Parkinson's disease, as well as neuroprotection. [4]

He received his doctorate in neuroanatomy from Thomas Jefferson University in 1989, [5] and undertook postdoctoral training at the Roche Institute of Molecular Biology studying with Dr. Jim Morgan and Tom Curran. [1] As a postdoctoral fellow, Dr. Smeyne, along with colleagues in the Morgan and Curran lab were one of the first to generate a transgenic mouse that expressed the transgene under the control of its cognate promoter. In 1992, following his postdoctoral work, he started his own lab at the Bristol Myers Squibb Pharmaceutical Research Center in Princeton NJ. At BMS, he collaborated with the lab of Dr. Mariano Baarbacid to generate and analyze mice carrying mutations of the neurotrophin receptors TrkA, TrkB and TrkC. In 1994, Dr. Smeyne left BMS and was named the Head of the Neurogenetics Program in the Division of CNS Research at Hoffmann-La Roche. In 1996 following the closure of the Roche Institute of Molecular Biology, Dr. Smeyne was recruited to the faculty at Saint Jude Children's Research Hospital, where he joined, as an Associate Member rising to Full Member, in the Department of Developmental Neurobiology. [6] It was at SJCRH that Dr. Smeyne started his research program examining the cellular and molecular underpinnings of Parkinson's disease. In 2016, after 20 years at SJCRH, Dr. Smeyne was recruited to Thomas Jefferson University as a Full Professor and to be Head of the Comprehensive Parkinson's Disease Center. Under his leadership, the JCPDC was named a Center of Excellence by the Parkinson's Foundation. [7]

Dr. Smeyne has had a long-standing interest in the cell biology of Parkinson’s disease, with studies examining both environmental and genetic causation.  His lab was one the first to show, [8] in animal models of PD, that exercise could modify disease progression , and more recently has been examining the underlying molecular programs responsible for this neuroprotection . He is also recognized for his work examining interactions of the peripheral immune system with that of the brain’s innate immune system immune as well as the role of viruses in the etiology of Parkinson’s disease.  Currently, Dr. Smeyne serves as the Chair of the Clinical and Scientific Advisory Board for the Parkinson’s Foundation. [9] His lab is currently funded by the NIH, the Parkinson’s Disease Foundation, and the Michael J Fox Foundation for Parkinson’s Research

According to PubMed, Dr. Smeyne has published 113 papers. He was recently named by research.com to the list of top 1,000 neuroscientists in the USA. [10]

Related Research Articles

<span class="mw-page-title-main">Salk Institute for Biological Studies</span> Scientific research institute in San Diego, US

The Salk Institute for Biological Studies is a scientific research institute located in the La Jolla community of San Diego, California, U.S. The independent, non-profit institute was founded in 1960 by Jonas Salk, the developer of the polio vaccine; among the founding consultants were Jacob Bronowski and Francis Crick. Construction of the research facilities began in spring of 1962. The Salk Institute consistently ranks among the top institutions in the US in terms of research output and quality in the life sciences. In 2004, the Times Higher Education Supplement ranked Salk as the world's top biomedicine research institute, and in 2009 it was ranked number one globally by ScienceWatch in the neuroscience and behavior areas.

<span class="mw-page-title-main">Neuroprotection</span> Relative preservation of neuronal structure and/or function

Neuroprotection refers to the relative preservation of neuronal structure and/or function. In the case of an ongoing insult the relative preservation of neuronal integrity implies a reduction in the rate of neuronal loss over time, which can be expressed as a differential equation. It is a widely explored treatment option for many central nervous system (CNS) disorders including neurodegenerative diseases, stroke, traumatic brain injury, spinal cord injury, and acute management of neurotoxin consumption. Neuroprotection aims to prevent or slow disease progression and secondary injuries by halting or at least slowing the loss of neurons. Despite differences in symptoms or injuries associated with CNS disorders, many of the mechanisms behind neurodegeneration are the same. Common mechanisms of neuronal injury include decreased delivery of oxygen and glucose to the brain, energy failure, increased levels in oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammatory changes, iron accumulation, and protein aggregation. Of these mechanisms, neuroprotective treatments often target oxidative stress and excitotoxicity—both of which are highly associated with CNS disorders. Not only can oxidative stress and excitotoxicity trigger neuron cell death but when combined they have synergistic effects that cause even more degradation than on their own. Thus limiting excitotoxicity and oxidative stress is a very important aspect of neuroprotection. Common neuroprotective treatments are glutamate antagonists and antioxidants, which aim to limit excitotoxicity and oxidative stress respectively.

Sir John Anthony Hardy is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.

<span class="mw-page-title-main">Ann Graybiel</span> American neuroscientist

Ann Martin Graybiel is an Institute Professor and a faculty member in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology. She is also an investigator at the McGovern Institute for Brain Research. She is an expert on the basal ganglia and the neurophysiology of habit formation, implicit learning, and her work is relevant to Parkinson's disease, Huntington's disease, obsessive–compulsive disorder, substance abuse and other disorders that affect the basal ganglia.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

Mark A. Gluck is a professor of neuroscience at Rutgers–Newark in New Jersey, director of the Rutgers Memory Disorders Project, and publisher of the public health newsletter, Memory Loss and the Brain. He works at the interface between neuroscience, psychology, and computer science, studying the neural bases of learning and memory. He is the co-author of Gateway to Memory: An Introduction to Neural Network Models of the Hippocampus and an undergraduate textbook Learning and Memory: From Brain to Behavior.

<span class="mw-page-title-main">Michel Goedert</span> Luxembourgish-British neuroscientist

Michel Goedert FRS, FMedSci is a Luxembourgish-British neuroscientist and former Head of Neurobiology, at the MRC Laboratory of Molecular Biology.

Kim Kwang-soo is a South Korean neuroscientist.

James O. McNamara is an American neurologist and neuroscientist, known for his research of epileptogenesis, the process underlying development and progression of epilepsy. He is the Duke School of Medicine Professor of Neuroscience in the Departments of Neurobiology, Neurology, and Pharmacology and Cancer Biology at Duke University. He served as chair of the Department of Neurobiology at Duke from 2002 to 2011

Patrick McNamara is an American neuroscientist. His work has centered on three major topics: sleep and dreams, religion, and mind/brain.

<span class="mw-page-title-main">Jonathan Kipnis</span> Neuroscientist

Jonathan Kipnis is a neuroscientist, immunologist, and professor of pathology and immunology at the Washington University School of Medicine. His lab studies interactions between the immune system and nervous system. He is best known for his lab's discovery of meningeal lymphatic vessels in humans and mice, which has impacted research on neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis, neuropsychiatric disorders, such as anxiety, and neurodevelopmental disorders such as autism and Rett syndrome.

Kochupurackal P. Mohanakumar is an Indian chemical biologist, neuroscientist and the director of Inter University Centre for Biomedical Research and Super Specialty Hospital, Kottayam. He is a former chief scientist at the Indian Institute of Chemical Biology and is known for his studies on Parkinson's disease and Huntington’s disease. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2000.

Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University, Professor of Neurology [Neuroscience] at Harvard Medical School, and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.

Tracy Bale is an American neuroscientist and molecular biologist. Bale is a professor and Director of the Center for Epigenetic Research in Child Health and Brain Development at the University of Maryland School of Medicine. Her research has centered on the role of parental, prenatal, and early life stress on the developing brain and subsequent behavior throughout the lifespan. She is also the current President of the International Brain Research Organization.

HollisT. Cline is an American neuroscientist and the Director of the Dorris Neuroscience Center at the Scripps Research Institute in California. Her research focuses on the impact of sensory experience on brain development and plasticity.

Moses V. Chao is a neuroscientist and university professor at NYU Langone Health Medical Center. He studies the mechanisms of neuronal growth factor and teaches courses in cell biology, neuroscience, and physiology. He is a Fellow of the American Association for the Advancement of Science and was President of the Society for Neuroscience in 2012.

Philip Lazarovici is a neuropharmacologist at the Hebrew University of Jerusalem and a member of the Institute of Drug Research of the School of Pharmacy.

<span class="mw-page-title-main">Judith S. Eisen</span> American neuroscientist

Judith S. Eisen is an American neuroscientist and professor of biology at the University of Oregon. Eisen conducts fundamental research in the specification and patterning of the vertebrate nervous system with a focus on developmental interactions between the nervous system, immune system, and host-associated microbiota. Eisen is a member of the Institute of Neuroscience at the University of Oregon.

Hilal Lashuel is an American-Yemeni neuroscientist and chemist, currently an associate professor at the EPFL. His research focuses on protein misfolding and aggregation in the pathogenesis of Alzheimer's and Parkinson's diseases.

<span class="mw-page-title-main">Elaine Hsiao</span> American biologist and academic

Elaine Yih-Nien Hsiao is an American biologist who is Professor in Biological Sciences at University of California, Los Angeles. Her research considers the microbes that impact human health. She was a 2022 Laureate for the Blavatnik Awards for Young Scientists.

References

  1. 1 2 "Scientific Advisory Board". Parkinson's Foundation . Retrieved 23 January 2023.
  2. "Richard J. Smeyne, PhD". Thomas Jefferson University . Retrieved 23 January 2023.
  3. "Parkinson's gene initiates disease outside of the brain". EurekAlert!. Retrieved 23 January 2023.
  4. "Richard Jay Smeyne, PhD". The Michael J. Fox Foundation . Retrieved 23 January 2023.
  5. "All the Right Moves". Thomas Jefferson University . Retrieved 23 January 2023.
  6. "Developmental Neurobiology".
  7. "Global Care Network | Parkinson's Foundation".
  8. Faherty, C. J.; Raviie Shepherd, K.; Herasimtschuk, A.; Smeyne, R. J. (2005). "Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism". Brain Research. Molecular Brain Research. 134 (1): 170–179. doi:10.1016/j.molbrainres.2004.08.008. PMID   15790541.
  9. "Scientific Advisory Board | Parkinson's Foundation".
  10. "World's Best Neuroscience Scientists: H-Index Neuroscience Science Ranking 2023 | Research.com".